Bloodlines Series: What Is Smoldering Myeloma?
Learn about smoldering myeloma and the first treatment approved by the U.S. Food and Drug Administration to prevent its...
Learn about smoldering myeloma and the first treatment approved by the U.S. Food and Drug Administration to prevent its...
Nina Bhardwaj, MD, PhD, co-chair of the AACR's special conference "Tumor Immunology and Immunotherapy: A New Chapter," discusses what...
Despite current screening efforts, colorectal cancer is the fourth most commonly diagnosed cancer worldwide and the fifth leading cause...
Costas Lyssiotis, PhD, a 2013 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant recipient, is conducting research to understand...
The National Cancer Institute’s Lee Helman, MD, co-chair of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, discusses...
Research has fueled significant progress against breast cancer—the overall five-year survival rate for female breast cancer patients in the...
In a Los Angeles Times op-ed, Cynthia Ryan, a two-time breast cancer survivor, past participant in the AACR Scientist↔Survivor...
According to a new report in Cancer Epidemiology, Biomarkers & Prevention, the levels of several toxic substances are elevated...
Lung cancer awareness month started hot on the heels of two exciting pieces of news that highlight the promise...
Cancer research has led to great progress in cancer prevention, detection, diagnosis, and treatment, improving and saving countless lives....
In follow up to the AACR Cancer Progress Report 2014, AACR President Carlos L. Arteaga, MD, discusses our continuing...